Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 2 of 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Study on the Mutation Sites of CSF3R Responsible for the Clonal Advantage of Chronic Neutrophilic Leukemia
    (Mongolian National University of Medical Sciences, 2016-06-25) ;
    Ming Feng Zhao
    ;
    Wu Ri Mao
    Objectives: Chronic neutrophilic leukemia (CNL) is a rare, but distinct, entity within myeloproliferative neoplasms, characterized by splenomegaly, sustained mature neutrophilia, and absence of the Philadelphia chromosome. In 2013, oncogenic mutations in colony stimulation factor 3 receptor (CSF3R) were identified in a majority of patients with CNL and it was demonstrated that their downstream signaling was sensitive to known kinase inhibitors. This discovery was then validated with the demonstration of 100% CSF3R mutational frequency (predominately CSF3R-T618I) in strictly CNL as defined by the World Health Organization (WHO). In September 2012, a 67-year-old Chinese man was admitted to the First Central Clinical College of Tianjin Medical University (Tianjin, China) and presented as a case who had fulfilled the WHO diagnostic criteria for CNL with a oncogenic mutation in CSF3R-T618I and also an unreported novel mutation site of CSF3R-H54A Thus, we sought to determine if CSF3R-FL, CSF3R-T618I, CSF3R-H54A mutations have some significance on the molecular pathogenesis of CNL. Methods: In this study, three main experiments were used including plasmid construction, lentiviral packaging system, and Mouse Colony-Forming Unit Assays Using MethoCult™. Results: The establishment of these three experiments was completed successfully. We confirmed the transformation capacity of the CSF3R mutations, especially that CSF3R-T618I was higher than CSF3R-FL Conclusion: This result demonstrates that T618I mutation of CSF3R conferred the clonal advantage of CNL leukemia cells.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Chronic neutrophilic leukemia with overexpression of EVI-1, and concurrent CSF3R and SETBP1 mutations: A case report
    (2015-09) ;
    Cao, Shannan
    ;
    Meng, Juanxia
    ;
    Liu, Peng
    ;
    Haiyan, Gong
    Chronic neutrophilic leukemia (CNL) is a rare type of myeloproliferative neoplasm, characterized by sustained neutrophilia, splenomegaly, bone marrow granulocytic hyperplasia (without evidence of dysplasia) and an absence of the Philadelphia chromosome. Thus far, ~150 cases of CNL have been described in the literature; however, none have demonstrated overexpression of the ecotropic viral integration site-1 (EVI-1, also known as MECOM) gene. The present study describes a case that fulfilled the World Health Organization diagnostic criteria for CNL, and was associated with overexpression of EVI-1, as well as novel concurrent mutations of colony stimulating factor 3 receptor (CSF3R) and SET binding protein-1 (SETBP1). In addition, the current study briefly reviewed the relevant literature regarding novel genetic findings associated with the diagnosis and treatment of CNL. To the best of our knowledge, this is the first case report of CNL with associated EVI-1 overexpression, and concurrent CSF3R and SETBP1 mutations.
    Scopus© Citations 3